GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » EBITDA Margin %

Notable Labs (Notable Labs) EBITDA Margin % : -4,645.16% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Notable Labs's EBITDA for the six months ended in Dec. 2023 was $-14.40 Mil. Notable Labs's Revenue for the six months ended in Dec. 2023 was $0.31 Mil. Therefore, Notable Labs's EBITDA margin for the quarter that ended in Dec. 2023 was -4,645.16%.


Notable Labs EBITDA Margin % Historical Data

The historical data trend for Notable Labs's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs EBITDA Margin % Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
EBITDA Margin %
-5,820.35 -157,512.50 -4,645.16

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
EBITDA Margin % -5,820.35 -157,512.50 -4,645.16

Competitive Comparison of Notable Labs's EBITDA Margin %

For the Biotechnology subindustry, Notable Labs's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Notable Labs's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Notable Labs's EBITDA Margin % falls into.



Notable Labs EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Notable Labs's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-14.4/0.31
=-4,645.16 %

Notable Labs's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-14.4/0.31
=-4,645.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Notable Labs  (NAS:NTBL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Notable Labs EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Notable Labs's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Notable Labs (Notable Labs) Business Description

Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.